Inhibition of miR-141 and miR-200a Increase DLC-1 and ZEB2 Expression, Enhance Migration and Invasion in Metastatic Serous Ovarian Cancer. This evidence concerns the gene DLC1 and ovarian serous adenocarcinoma.